OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults
Amy Thomas, Elizabeth Oliver, Holly E. Baum, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 14

Showing 14 citing articles:

Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
Michael W. Russell, Jiří Městecký
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 77

Developing Deep LSTMs With Later Temporal Attention for Predicting COVID-19 Severity, Clinical Outcome, and Antibody Level by Screening Serological Indicators Over Time
Jiaxin Cai, Yang Li, Baichen Liu, et al.
IEEE Journal of Biomedical and Health Informatics (2024) Vol. 28, Iss. 7, pp. 4204-4215
Closed Access | Times Cited: 19

Silent battles: immune responses in asymptomatic SARS-CoV-2 infection
Nina Le Bert, Taraz Samandari
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 159-170
Closed Access | Times Cited: 8

Point-of-Care Diagnostic Biosensors to Monitor Anti-SARS-CoV-2 Neutralizing IgG/sIgA Antibodies and Antioxidant Activity in Saliva
Eiichi Tamiya, Shuto Osaki, Tomoko Tsuchihashi, et al.
Biosensors (2023) Vol. 13, Iss. 2, pp. 167-167
Open Access | Times Cited: 5

Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial
Holly E. Baum, Russell Thirard, Alice Halliday, et al.
Vaccine (2024) Vol. 42, Iss. 12, pp. 2945-2950
Closed Access | Times Cited: 1

Applications of SARS-CoV-2 serological testing: impact of test performance, sample matrices, and patient characteristics
Chun Yiu Jordan Fung, Mackenzie Scott, Jordan Lerner‐Ellis, et al.
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 61, Iss. 1, pp. 70-88
Closed Access | Times Cited: 4

SARS-CoV-2-Specific Immune Responses in Vaccination and Infection during the Pandemic in 2020–2022
Wakana Inoue, Yuta Kimura, Shion Okamoto, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 446-446
Open Access

The Impact of Vaccine Type and Booster Dose on the Magnitude and Breadth of Sars-Cov-2-Specific Mucosal Iga
Hoi‐Wah Tsoi, Miko Ka-Wai Ng, Jian‐Piao Cai, et al.
(2024)
Closed Access

Hybrid adaptive immunity to SARS-CoV-2 protects against breakthrough infection after COVID-19 vaccination in ALSPAC participants.
Holly E. Baum, Marianna Santopaolo, Ore Francis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Salivary IgG antibody response against SARS-CoV-2 differs between vaccinated children and adults
María Noel Badano, Irene Keitelman, Matías J. Pereson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
Helen Ratcliffe, Karen S. Tiley, Stephanie Longet, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108500-108500
Open Access | Times Cited: 1

Page 1

Scroll to top